# OMEPRAZOLE AND SODIUM BICARBONATE
> **ANDA205545** · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2016-07-27
## Drug
- **FDA Application Number:** ANDA205545
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OMEPRAZOLE AND SODIUM BICARBONATE
- **Generic name:** OMEPRAZOLE AND SODIUM BICARBONATE
- **Active ingredients:** OMEPRAZOLE; SODIUM BICARBONATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AJANTA PHARMA LTD
- **Manufacturer:** Ajanta Pharma USA Inc.
- **First approval:** 2016-07-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205545)
---
*AI Analytics · CC0 1.0*